Transforming Growth Factor Beta Receptor II
TGFBR2geneTGFBR2 mediates TGF-β signaling controlling smooth-muscle proliferation and extracellular-matrix remodeling during fibrous-cap thinning.
Pathway placement
Cascade stepFibrous-cap degradation & rupture
Confidencemedium
RationaleTGF-β signaling regulates ECM synthesis and smooth-muscle migration during cap degradation.
Also acts inVascular inflammation
Druggability
DruggableYes
Known drugs / candidates0
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000163513
Type I vs Type II discrimination
ScoresLow-confidence (proxy)
R — rupture / Type-I30
C — confounder / Type-II59
A — assay feasibility52
E — evidence strength22
T1DI (composite)4
Specificity differential (R−C)-29.2
Confounder panel (Type-II drivers)
No confounder evidence retrieved.
Tier: light (literature co-occurrence proxy — lower confidence). See the discrimination table for all markers.
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Whole blood — gene is not a circulating analyte; measure protein product or genotype
Collection tube
K2-EDTA whole blood (lavender-top)
Method / principle
SNP genotyping / sequencing; or immunoassay of encoded protein
Reagent / substrate
Allele-specific primers/probes (TaqMan) or NGS panel; or antibody for protein
Platform
qPCR / NGS / array
Turnaround · availability
Send-out · Genotyping widely available; protein assay variable
Literature evidence(1)
- miR-520e and its promoter region DNA methylation as potential biomarkers in atherosclerosis.Biochemistry and cell biology = Biochimie et biologie cellulaire · 2024 · PMID 38917487 · doi